A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases

I. Zalaudek, A. Ciarrocchi, S. Piana, G. Argenziano, F. Torricelli, V. Sancisi, G. Gandolfi, C. Longo, E. Moscarella, C. Banzi, D. Nicoli

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread. However, it appears that amelanotic melanomas frequently lack BRAF mutations. Objective: To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Methods: The BRAF mutational status of the primary lesion was assessed by both Sanger sequencing and pyrosequencing. Results: Both methodologies showed changes in three nucleotides: C1796T; G1798A and T1799A. These mutations should result in a rare double aminoacid substitution in codons 599 and 600 of the BRAF protein (BRAF T599I/V600K). Conclusion: This unusual mutation was associated with an uncommon clinical phenotype of the primary tumour and with an unusual site of metastatic spread. In the lack of comparable data, a potential association between the unusual mutation and clinical findings remains a matter of further studies.

Original languageEnglish
Pages (from-to)387-390
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Amelanotic Melanoma
Neoplasm Metastasis
Mutation
Phenotype
Codon
Molecular Biology
Melanoma
Nucleotides
Neoplasms
Proteins

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases
  • Medicine(all)

Cite this

A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. / Zalaudek, I.; Ciarrocchi, A.; Piana, S.; Argenziano, G.; Torricelli, F.; Sancisi, V.; Gandolfi, G.; Longo, C.; Moscarella, E.; Banzi, C.; Nicoli, D.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 29, No. 2, 01.02.2015, p. 387-390.

Research output: Contribution to journalArticle

@article{2c5b658ed70749d0975a8f7bb1f1102b,
title = "A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases",
abstract = "Background: In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread. However, it appears that amelanotic melanomas frequently lack BRAF mutations. Objective: To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Methods: The BRAF mutational status of the primary lesion was assessed by both Sanger sequencing and pyrosequencing. Results: Both methodologies showed changes in three nucleotides: C1796T; G1798A and T1799A. These mutations should result in a rare double aminoacid substitution in codons 599 and 600 of the BRAF protein (BRAF T599I/V600K). Conclusion: This unusual mutation was associated with an uncommon clinical phenotype of the primary tumour and with an unusual site of metastatic spread. In the lack of comparable data, a potential association between the unusual mutation and clinical findings remains a matter of further studies.",
author = "I. Zalaudek and A. Ciarrocchi and S. Piana and G. Argenziano and F. Torricelli and V. Sancisi and G. Gandolfi and C. Longo and E. Moscarella and C. Banzi and D. Nicoli",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/jdv.12358",
language = "English",
volume = "29",
pages = "387--390",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "2",

}

TY - JOUR

T1 - A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases

AU - Zalaudek, I.

AU - Ciarrocchi, A.

AU - Piana, S.

AU - Argenziano, G.

AU - Torricelli, F.

AU - Sancisi, V.

AU - Gandolfi, G.

AU - Longo, C.

AU - Moscarella, E.

AU - Banzi, C.

AU - Nicoli, D.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread. However, it appears that amelanotic melanomas frequently lack BRAF mutations. Objective: To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Methods: The BRAF mutational status of the primary lesion was assessed by both Sanger sequencing and pyrosequencing. Results: Both methodologies showed changes in three nucleotides: C1796T; G1798A and T1799A. These mutations should result in a rare double aminoacid substitution in codons 599 and 600 of the BRAF protein (BRAF T599I/V600K). Conclusion: This unusual mutation was associated with an uncommon clinical phenotype of the primary tumour and with an unusual site of metastatic spread. In the lack of comparable data, a potential association between the unusual mutation and clinical findings remains a matter of further studies.

AB - Background: In the context of amelanotic melanoma, little is known on the genetic or molecular background that determines the onset of this peculiar phenotype of melanoma and its sites of metastatic spread. However, it appears that amelanotic melanomas frequently lack BRAF mutations. Objective: To report the genetical analysis of one case amelanotic melanoma developing oral metastasis. Methods: The BRAF mutational status of the primary lesion was assessed by both Sanger sequencing and pyrosequencing. Results: Both methodologies showed changes in three nucleotides: C1796T; G1798A and T1799A. These mutations should result in a rare double aminoacid substitution in codons 599 and 600 of the BRAF protein (BRAF T599I/V600K). Conclusion: This unusual mutation was associated with an uncommon clinical phenotype of the primary tumour and with an unusual site of metastatic spread. In the lack of comparable data, a potential association between the unusual mutation and clinical findings remains a matter of further studies.

UR - http://www.scopus.com/inward/record.url?scp=84921612119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921612119&partnerID=8YFLogxK

U2 - 10.1111/jdv.12358

DO - 10.1111/jdv.12358

M3 - Article

C2 - 24393566

AN - SCOPUS:84921612119

VL - 29

SP - 387

EP - 390

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 2

ER -